jiayi-li23/proxann_data huggingface dataset:
Bill 114-S-480 — Health / Drug and Alcohol Abuse
Subject: Health

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

 (Sec. 3) This bill amends the Public Health Service Act to revise and extend through FY2021 the controlled substance monitoring program, including to:

 allow grants to be used to maintain existing state controlled substance monitoring programs; require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees; require states to report on the interoperability of their programs with federal programs and health information technology systems and whether their programs provide automatic, up-to-date, or daily information about a patient upon request; require states to provide HHS with aggregate data and other information to enable HHS to evaluate the success of state programs; and expand the program to include any commonwealth or territory of the United States. The Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

HHS is no longer required to give preference for grants related to drug abuse to states with controlled substance monitoring programs.

 A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system.
Bill 114-S-636 — Health / Drug and Alcohol Abuse
Subject: Health

Increasing the Safety of Prescription Drug Use Act of 2015

This bill amends the Public Health Service Act to revise, update, and expand state controlled substance monitoring programs, which ensure that prescription history information is accessible for investigations into drug diversion and errant prescribing and dispensing practices.

A state's controlled substance monitoring program database must be interoperable with other states' databases and electronic health records, and must provide up-to-date patient information to practitioners. Practitioners and dispensers are required to use the database.

Database information cannot be used to conduct a criminal investigation against a patient. Certain entities are allowed to make nonidentifiable information from a database available for research.

Federal health care workers must screen patients for abuse of controlled substances, conduct brief interventions, and provide referrals for known or suspected abuse of controlled substances.

Grants are established for: (1) a pilot project to develop a peer review process to evaluate prescribing and pharmacy dispensing patterns, (2) training health care providers to prevent controlled substance abuse, (3) evaluating the prospect of health professions boards reviewing the prescribing authorities of providers, and (4) developing criteria and processes that allow health professions boards or state agencies to certify education and training for informed and safe prescribing of certain controlled substances.

Practitioners who register or renew a registration with the Drug Enforcement Administration to dispense or conduct research with controlled substances must have completed specified continuing medical education. A registered practitioner must screen patients for drug abuse before prescribing certain controlled substances.

The Food and Drug Administration must consider whether naloxone (a drug used to rapidly reverse overdoses of heroin and other opiods) should be a behind-the-counter drug instead of a prescription drug.

This bill amends the Controlled Substances Act to increase the number of patients a practitioner is allowed to treat by dispensing narcotic drugs for maintenance or detoxification.
Bill 114-S-707 — Health / Drug and Alcohol Abuse
Subject: Health

Opioid Overdose Reduction Act of 2015

This bill exempts individuals from liability for harm caused by the emergency administration of an opioid overdose drug under certain circumstances. (An opioid is a drug with effects similar to opium, such as heroin.) The individuals exempted from liability are:

 a health care professional who prescribes or provides an opioid overdose drug to an individual at risk of experiencing an opioid overdose or to another individual in a position to assist an at-risk individual, if the individual prescribed or provided the drug has been educated about opioid overdose prevention and treatment by the health care professional or as part of a government opioid overdose program; an individual who provides an opioid overdose drug for emergency administration to another individual authorized to receive it as part of an opioid overdose program; and an individual who administers an opioid overdose drug to another individual who appears to have suffered an opioid overdose if the administering individual obtained the drug from a health care professional or as part of an opioid overdose program and was educated by the professional or program in the proper administration of the drug. These exemptions are inapplicable if the harm was caused by gross negligence or reckless misconduct.

States can preempt these exemptions by providing additional protections from liability for individuals that administer opioid overdose drugs, or by enacting legislation making this Act not applicable to state civil action involving only citizens from that state.
Bill 114-S-728 — Health / Drug and Alcohol Abuse
Subject: Health

Sober Truth on Preventing Underage Drinking Reauthorization Act or the STOP Act

Amends the Public Health Service Act to reauthorize the program to reduce underage drinking for FY2016-FY2019.

Revises reporting requirements for state programs on underage drinking.

 Specifies additional requirements for the development of the national media campaign to prevent underage drinking.

Directs the Substance Abuse and Mental Health Services Administration to make grants to professional pediatric provider organizations to increase effective practices, including the screening of children and adolescents for alcohol use, to reduce the prevalence of alcohol use among individuals under the age of 21, including college students.

Directs the Department of Health and Human Services to collect data and conduct or support new research on underage drinking that carries out and improves public health surveillance of alcohol use and alcohol-related conditions in states among individuals between age 18 and 20 by increasing the use of surveys, such as the Behavioral Risk Factor Surveillance System, to monitor binge and excessive drinking and related harms.

Amends the Federal Alcohol Administration Act to prohibit the manufacture, sale, distribution, or possession of powdered alcohol.
Bill 114-S-1134 — Health / Drug and Alcohol Abuse
Subject: Health

Heroin and Prescription Opioid Abuse Prevention, Education, and Enforcement Act of 2015

This bill requires the Department of Health and Human Services (HHS), in cooperation with the Department of Veterans Affairs, the Department of Defense, and the Drug Enforcement Administration, to convene a Pain Management Best Practices Inter-Agency Task Force to develop and study best practices for pain management and prescription of pain medication.

The Harold Rogers Prescription Drug Monitoring Program is extended through FY2020. The Government Accountability Office must evaluate the effectiveness of this program in reducing prescription drug abuse and any corresponding increase or decrease in the use of heroin.

This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to extend the Edward Byrne Memorial Justice Assistance Grant Program through FY2020.

HHS must advance education and awareness of the risk of abuse of prescription opioids (drugs with effects similar to opium).

The Office of National Drug Control Policy (ONDCP), in coordination with HHS and the Department of Justice (DOJ), must establish a national drug awareness campaign that emphasizes the similarities between heroin and prescription opioids and increases awareness of the dangerous effects of mixing fentanyl (a prescription opioid painkiller) with heroin.

DOJ, in coordination with HHS and ONDCP, may make grants to state, local, or tribal governments to create demonstration programs to allow first responders to prevent opioid overdose death by administering an opioid overdose reversal drug (e.g., naloxone). Priority must be given to entities in states that provide civil liability protection for first responders administering a drug to counteract opioid overdoses.
Bill 114-S-1410 — Health / Drug and Alcohol Abuse
Subject: Health

Treatment and Recovery Investment Act

This bill amends the Public Health Service Act to authorize the Center for Substance Abuse Treatment to award grants to state agencies responsible for administering funds received under the substance abuse prevention and treatment block grant program, to local governments that have a high rate of, or have had a rapid increase in, the use of, or death related to the use of, heroin or other opioids (including prescription opioids), and to Indian tribes or tribal organizations in order to permit such entities to expand evidence-based treatment activities and related recovery services.

The Center shall award: (1) five-year grants to state substance abuse agencies, Indian tribes or tribal organizations, and public nonprofit entities to enhance access to primary care and related services for pregnant and parenting women diagnosed with opioid dependence; and (2) grants, contracts, or cooperative agreements of up to five years duration to eligible state substance abuse agencies and other appropriate entities to increase the capacity of substance use disorder treatment and recovery services for adolescents.

The Substance Abuse and Mental Health Services Administration shall award grants to state substance abuse agencies and non-profit organizations to develop, expand, and enhance recovery support services for individuals with substance use disorders.

The amount authorized under the substance abuse prevention and treatment block grant program is increased: (1) to a specified amount for FY2016, and (2) by the annual percentage increase in the Consumer Price Index for each subsequent year.

The Comptroller General shall evaluate and report on the in-patient and outpatient treatment capacity, availability, and needs of the United States.
Bill 114-S-1431 — Health / Drug and Alcohol Abuse
Subject: Health

Prescription Drug Abuse Prevention and Treatment Act of 2015

This bill amends the Public Health Service Act to require the Substance Abuse and Mental Health Services Administration (SAMHSA) to award grants for consumer education about opioid abuse. (Opioids are drugs with effects similar to opium, such as heroin or certain prescription painkillers.)

This bill amends the Controlled Substances Act to require medical practitioners to be trained in the treatment of opioid-dependent patients, pain management, and early detection of opioid addiction before they can be registered by the Drug Enforcement Administration to dispense opioids.

Opioid treatment programs that close on any day must make arrangements for each patient to receive treatment during the closure, as necessary.

A report must be submitted to SAMHSA for each individual who dies while receiving treatment in an opioid treatment program. In states receiving funding for controlled substance monitoring programs, deaths where an opioid drug is detected in the body must be reported to SAMHSA.

The National Center for Health Statistics of the Centers for Disease Control and Prevention must establish a National Opioid Death Registry to track opioid-related deaths.

The Agency for Healthcare Research and Quality must develop and apply prescription drug abuse prevention and treatment quality measures.

This bill amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to allow prescription drug plan (PDP) sponsors to limit the access of certain beneficiaries to frequently abused drugs. PDP sponsors must have a utilization management tool to prevent drug abuse.

Medicare Drug Integrity Contractors may accept prescription and medical records to determine whether a beneficiary is at risk for prescription drug abuse.
Bill 114-S-1654 — Health / Drug and Alcohol Abuse
Subject: Health

Overdose Prevention Act

This bill amends the Public Health Service Act to require the Substance Abuse and Mental Health Services Administration (SAMHSA) to enter into cooperative agreements to reduce deaths from drug overdoses by: (1) purchasing and distributing naloxone (a medication that rapidly reverses overdose from heroin or other drugs with effects similar to opium) or a similar drug; and (2) educating or training the public, first responders, or health professionals on drug overdose prevention or response.

SAMHSA must establish a coordinating center and develop a plan to reduce drug overdose deaths by educating the public about overdose prevention and recommending improvements to overdose prevention programs.

The Centers for Disease Control and Prevention must improve drug overdose surveillance by entering into cooperative agreements to: (1) provide training to improve identification of drug overdose as the cause of death, and (2) establish a national program for reporting drug overdoses.

The National Institute on Drug Abuse (NIDA) must prioritize, conduct, and support research on circumstances that contribute to drug overdose, drugs associated with fatal overdose, and overdose prevention methods. NIDA must support research on drug overdose treatments that can be administered by lay persons or first responders.
Bill 114-S-1913 — Health / Drug and Alcohol Abuse
Subject: Health

Stopping Medication Abuse and Protecting Seniors Act of 2015

This bill amends title XVIII (Medicare) of the Social Security Act to: (1) authorize a Medicare prescription drug plan (PDP) sponsor to establish a drug management program under which the PDP sponsor may limit an at-risk beneficiary’s access to coverage for frequently abused drugs to include only those drugs that are prescribed by selected prescribers and dispensed by selected pharmacies; and (2) require a PDP sponsor to have in place a utilization management tool to prevent drug abuse.

With respect to a drug management program, a PDP sponsor must: (1) provide specified notice to a beneficiary who has been identified by the Centers for Medicare & Medicaid (CMS) as “at-risk” and consequently enrolled in the program; and (2) in selecting prescribers and dispensers, ensure that the beneficiary continues to have reasonable access to drugs. These determinations shall be subject to expedited reconsideration and appeal. A PDP sponsor must review and consider an at-risk beneficiary’s preferences regarding prescriber and pharmacy selection.

Certain individuals, including those receiving hospice care or residing in a long-term care facility, are exempted from enrollment in a drug management program.

CMS must, for purposes of quality or performance assessments, review and consider complaints received from at-risk beneficiaries regarding lack of access due to their enrollment in a drug management program. In addition, CMS must establish rules and procedures requiring a PDP sponsor to provide specified program data.
Bill 114-S-2241 — Health / Drug and Alcohol Abuse
Subject: Crime and law enforcement

Combat Heroin Epidemic and Backlog Act of 2015

This bill amends the Omnibus Crime Control and Safe Streets Act of 1968 to authorize the Department of Justice's Bureau of Justice Assistance to award grants to state and tribal governments to address the distribution, sale, and use of heroin, fentanyl, and associated synthetic drugs.

 Grants may be used to:

 reimburse forensic science laboratories for efforts to address and prevent testing backlogs; reimburse law enforcement agencies for equipment to identify or detect heroin, fentanyl, and associated synthetic drugs; investigate, arrest, and prosecute distributors or sellers; and support health department services for users.
Bill 114-S-2423 — Health / Drug and Alcohol Abuse
Subject: Health

This bill provides FY2016 supplemental appropriations for the Department of Justice (DOJ) and the Department of Health and Human Services (HHS) to address heroin and opioid drug abuse. The funds are designated as an emergency requirement, which exempts the funds from discretionary spending limits and other budget enforcement rules.

For DOJ, the bill provides funds for State and Local Law Enforcement Assistance and Community Oriented Policing Services (COPS) programs.

For HHS, the bill provides funds for:

 the Substance Abuse and Mental Health Services Administration, the Centers for Disease Control and Prevention, the National Institutes of Health, and the Public Health and Social Services Emergency Fund.
Bill 114-S-2562 — Health / Drug and Alcohol Abuse
Subject: Health

Heroin and Prescription Drug Abuse Prevention and Reduction Act

This bill amends the Controlled Substances Act to revise requirements for and limitations on practitioners who dispense narcotic drugs for maintenance or detoxification treatment.

The Department of Health and Human Services (HHS) must establish grant programs to: (1) encourage prescribing and purchase of opioid overdose reversal drugs (e.g., naloxone), and (2) develop prescribing guidelines for such drugs. (Opioids are drugs with effects similar to opium, such as heroin or certain pain medications.)

The Centers for Disease Control and Prevention must provide support to improve drug overdose surveillance and reporting capabilities.

HHS may support syringe exchange programs.

The Substance Abuse and Mental Health Services Administration must provide support to reduce drug overdose deaths.

This bill amends the Public Health Service Act to extend residential treatment programs for pregnant and postpartum women.

HHS must: (1) carry out a pilot program to support services for pregnant and postpartum women with a substance use disorder; (2) award grants to expand treatment activities in areas with a high rate of, or a rapid increase in, the use of opioids; (3) support increasing the capacity of substance use disorder services for adolescents; and (4) develop, expand, and enhance substance use recovery support services.

This bill amends the Employee Retirement Income Security Act of 1974 (ERISA) and Internal Revenue Code to direct HHS and the Departments of Labor and the Treasury to require disclosures, issue guidance, conduct audits, and publish information regarding the requirement for group health plans and health insurance coverage to have parity between mental health and substance use disorder benefits and medical and surgical benefits. HHS must establish a consumer parity portal website.

HHS must establish a loan repayment program for substance use disorder health professionals.
Bill 114-S-2605 — Health / Drug and Alcohol Abuse
Subject: Health

Medicaid Coverage for Addiction Recovery Expansion Act

This bill amends title XIX (Medicaid) of the Social Security Act to allow states to provide medical assistance to adults for residential addiction treatment facility services under the Medicaid program. "Residential addiction treatment facility services" are medically necessary inpatient services provided in an accredited, size-limited facility for the purpose of treating a substance use disorder within a specified time period.

The provision of medical assistance for such services to an individual shall not prohibit federal financial participation for medical assistance with respect to other services provided to the individual within the same time period.

Subject to specified conditions, a woman who is eligible for medical assistance on the basis of being pregnant may remain eligible for residential addiction treatment facility services for specified time periods without regard to eligibility limits that would otherwise apply as a result of her pregnancy ending.

In addition, the bill establishes a grant program for states to expand infrastructure and treatment capabilities of existing youth addiction treatment facilities that: (1) provide addiction treatment services to youths under Medicaid or the Children's Health Insurance Program (CHIP), and (2) are located in communities with high numbers of medically underserved populations of at-risk youths. At least 15% of grant funds awarded to a state must be used for making payments to rural facilities.
Bill 110-HR-458 — Housing / General
Subject: Housing and community development

Public Housing Tenants Respect Act of 2007 - Amends the United States Housing Act of 1937 to repeal its public housing community service and family self-sufficiency requirements.
Bill 110-HR-644 — Housing / General
Subject: Environmental protection

Brownfields Redevelopment Enhancement Act - Amends the Housing and Community Development Act of 1974 to authorize the Secretary of Housing and Urban Development to make grants (without certain otherwise-required loan guarantees) to eligible public entities and Indian tribes to assist in the environmental cleanup and economic development of brownfield sites including mine-scarred lands. Prohibits: (1) providing or using such grants in a manner that reduces the financial responsibility of any nongovernmental party that is responsible or potentially responsible for contamination on any real property; and (2) the provision of assistance pursuant to this section from in any way relieving any party of liability with respect to such contamination, including liability for removal and remediation costs. Authorizes FY2008-FY2012 appropriations. Defines "brownfield site" for purposes of this Act. Makes brownfields-related environmental cleanup and economic development activities eligible for community development block grant (CDBG) assistance. Authorizes CDBG use to administer renewal communities.
Bill 110-HR-647 — Housing / General
Subject: Housing and community development

Mark-to-Market Extension Act of 2007 - Amends the Multifamily Assisted Housing Reform and Affordability Act of 1997 to reauthorize through FY2011: (1) the Federal Housing Administration (FHA)-insured Multifamily Housing Mortgage and Housing Assistance Restructuring (Mark-to-Market) program; and (2) the Office of Multifamily Housing Assistance Restructuring. Permits the Secretary of Housing and Urban Development to waive rent level limits for: (1) disaster-damaged eligible projects; and (2) up to 9% (currently 5%) of all units subject to restructured mortgages in any fiscal year, based on certain findings of special need. Redefines multifamily housing project eligible for the Mark-to-Market program to authorize eligibility treatment, upon owner request, for certain projects whose rents do not, on an average per unit or per room basis, exceed the rent of comparable properties in the same market area, if the Secretary determines that such treatment is necessary to preserve a project in the most cost-effective manner in relation to other alternative preservation options. Requires each mortgage restructuring and rental assistance sufficiency plan to determine, for units assisted with project-based assistance in eligible multifamily housing projects, adjusted rent levels for disaster-damaged eligible projects equal to 100% of the fair market rents for the relevant market area. Revises requirements for an approved mortgage restructuring and rental assistance sufficiency plan with respect to modification or forgiveness of all or part of a second mortgage held by the Secretary (debt relief) if the project concerned is acquired by a tenant organization or tenant-endorsed community-based nonprofit or public agency. Sets forth requirements for alternative periods of eligibility for such nonprofit debt relief if the purchaser acquires the project subsequent to the date of recordation of the related affordability agreement.